Cost-Utility Analysis of the National truth® Campaign to Prevent Youth Smoking

被引:46
作者
Holtgrave, David R. [1 ]
Wunderink, Katherine A. [2 ]
Vallone, Donna M. [2 ]
Healton, Cheryl G. [2 ]
机构
[1] Johns Hopkins Univ, Dept Hlth Behav & Soc, John Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[2] Amer Legacy Fdn, Washington, DC USA
关键词
TOBACCO-USE;
D O I
10.1016/j.amepre.2009.01.020
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In 2005, the American journal of Public Health published an article that indicated that 22% of the overall decline in youth smoking that occurred between 1999 and 2002 was directly attributable to the truth (R) social marketing campaign launched in 2000. A remaining key question about the truth campaign is whether the economic investment in the program can be justified by the public health outcomes; that question is examined here. Methods: Standard methods of cost and cost-utility analysis were employed in accordance with the U.S. Panel on Cost-Effectiveness in Health and Medicine; a societal perspective was employed. Results: During 2000-2002, expenditures totaled just over $324 million to develop, deliver, evaluate, and litigate the truth campaign. The base-case cost-utility analysis result indicates that the campaign was cost saving; it. is estimated that the campaign recouped its costs and that just under $1.9 billion in medical costs was averted for society. Sensitivity analysis indicated that the basic determination of cost effectiveness for this campaign is robust to substantial variation in input parameters. Conclusions: This Study suggests that the truth campaign not only markedly improved the public's health but did so in an economically efficient manner. (Am J Prev Med 2009;36(5):385-388) (c) 2009 American Journal, of Preventive Medicine
引用
收藏
页码:385 / 388
页数:4
相关论文
共 17 条
[1]  
[Anonymous], 1996, Cost-effectiveness in health and medicine
[2]  
Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625
[3]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P785
[4]   A comprehensive league table of cost-utility ratios and a sub-table of "Panel-worthy" studies [J].
Chapman, RH ;
Stone, PW ;
Sandberg, EA ;
Bell, C ;
Neumann, PJ .
MEDICAL DECISION MAKING, 2000, 20 (04) :451-467
[5]   Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence [J].
Farrelly, MC ;
Davis, KC ;
Haviland, L ;
Messeri, P ;
Healton, CG .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (03) :425-431
[6]  
GANTZ W, 2008, PUBLICATION KAISER F, V7715
[7]   What fraction of young adults are at risk for future smoking, and who are they? [J].
Gilpin, EA ;
White, VM ;
Pierce, JP .
NICOTINE & TOBACCO RESEARCH, 2005, 7 (05) :747-759
[8]   HIV prevention, cost-utility analysis, and race/ethnicity: Methodological considerations and recommendations [J].
Holtgrave, DR .
MEDICAL DECISION MAKING, 2004, 24 (02) :181-191
[9]  
JOHNSTON LD, 2002, NIH PUBLICATION, P503
[10]   Modeling quality-adjusted life expectancy loss resulting from tobacco use in the United States [J].
Kaplan, Robert M. ;
Anderson, John P. ;
Kaplan, Cameron M. .
SOCIAL INDICATORS RESEARCH, 2007, 81 (01) :51-64